Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular Biology of the Cell|August 28, 2015
Loss of endogenous Nfatc1 reduces the rate of DMBA/TPA-induced skin tumorigenesisJill Goldstein, Eve Roth, Natalie Roberts, et al.
The Milbank Quarterly|December 25, 2023
Four System Enablers of Large-System Transformation in Health Care: A Mixed Methods Realist EvaluationEmilie Francis-Auton, Janet C Long, Mitchell Sarkies, et al.
Communications Biology|March 7, 2020
Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapyVarunya Chantadul, Gareth S A Wright, Kangsa Amporndanai, et al.
Implementation Science : IS|December 12, 2023
Audit and feedback to reduce unwarranted clinical variation at scale: a realist study of implementation strategy mechanismsMitchell Sarkies, Emilie Francis-Auton, Janet Long, et al.
Orphanet Journal of Rare Diseases|October 22, 2025
"Just realising that I wasn't alone… was profound": a mixed-methods evaluation of a pilot peer-to-peer wellbeing program for carers of children with rare epilepsiesKristine Pierce, Jack Bernard Murphy, Eden G Robertson, et al.
BMC Health Services Research|January 4, 2023
What do consumer and providers view as important for integrated care? A qualitative studyAnn Carrigan, Natalie Roberts, Robyn Clay-Williams, et al.
BMC Health Services Research|July 3, 2023
The diversity of providers' and consumers' views of virtual versus inpatient care provision: a qualitative studyRobyn Clay-Williams, Peter Hibbert, Ann Carrigan, et al.
BMJ Open|November 17, 2022
Innovative models of care for the health facility of the future: a protocol for a mixed-methods study to elicit consumer and provider viewsAnn Carrigan, Natalie Roberts, Robyn Clay-Williams, et al.
BMC Health Services Research|March 6, 2024
Implementation of large, multi-site hospital interventions: a realist evaluation of strategies for developing capabilityJanet C Long, Natalie Roberts, Emilie Francis-Auton, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Pageof 3